A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa

Clinical trial NCT02448680 · COMPLETED

Trial details

NCT number: NCT02448680
Sponsor: Laboratoire français de Fractionnement et de Biotechnologies
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophilia A With Inhibitors Hemophilia B With Inhibitors

Start date: 2015-12-07
Primary completion: 2017-06-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.